TORAY INTERNATIONAL U.K

Company snapshot

Toray International U.K is a pharma organization headquartered in GB. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (1).

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for TORAY INTERNATIONAL U.K. Not investment advice.

• What is TORAY INTERNATIONAL U.K?

  Toray International U.K is a pharma organization headquartered in GB. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 1 (1).

• Is TORAY INTERNATIONAL U.K publicly traded?

  TORAY INTERNATIONAL U.K appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does TORAY INTERNATIONAL U.K develop or market?

  We link 8 drug profile(s) where TORAY INTERNATIONAL U.K is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/toray-international-u-k-limited#company-drugs.

• What are the latest developments for TORAY INTERNATIONAL U.K?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does TORAY INTERNATIONAL U.K focus on?

  No specific therapeutic focus areas are currently identified for TORAY INTERNATIONAL U.K in our database.